INO
Inovio Pharmaceuticals Inc
NASDAQ: INO · HEALTHCARE · BIOTECHNOLOGY
$1.12
+0.00% today
Updated 2026-04-30
Market cap
$95.46M
P/E ratio
—
P/S ratio
1,460.95x
EPS (TTM)
$-1.81
Dividend yield
—
52W range
$1 – $3
Volume
1.8M
Inovio Pharmaceuticals Inc (INO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+26.4%
Last 4 quarters
Revenue YoY growth
-155.9%
Most recent quarter
EPS YoY growth
+53.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.3%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.7%
2025-11-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-13 | $-0.28 | +19.6% | $1.68 | $1.63 | -3.0% |
| 2025-11-10 | $-0.87 | +12.1% | $2.12 | $2.00 | -5.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.35 | $-0.28 | +19.6% | $-65343.00 | -155.9% |
| 2025-09-30 | $-0.99 | $-0.87 | +12.1% | — | — |
| 2025-06-30 | $-1.07 | $-0.61 | +43.0% | — | — |
| 2025-03-31 | $-0.74 | $-0.51 | +31.1% | $65343.00 | — |
| 2024-12-31 | $-0.83 | $-0.60 | +27.9% | $116994.00 | +14.0% |
| 2024-09-30 | $-1.15 | $-0.89 | +22.6% | — | — |
| 2024-06-30 | $-1.10 | $-1.19 | -8.2% | $100762.00 | -55.4% |
| 2024-03-31 | $-1.00 | $-1.31 | -31.0% | — | — |
| 2023-12-31 | $-1.27 | $-1.12 | +11.8% | $102651.00 | — |
| 2023-09-30 | $-0.13 | $-0.13 | +0.0% | $388446.00 | — |
| 2023-06-30 | $-0.14 | $-0.13 | +7.1% | $225971.00 | — |
| 2023-03-31 | $-0.14 | $-0.16 | -14.3% | $114943.00 | — |
Frequently asked questions
Has Inovio Pharmaceuticals Inc beaten earnings estimates?
Inovio Pharmaceuticals Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +26.4% over the last 4 quarters.
How does INO stock react to earnings?
INO stock has moved an average of -4.3% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Inovio Pharmaceuticals Inc's revenue growth rate?
Inovio Pharmaceuticals Inc reported year-over-year revenue growth of -155.9% in its most recent quarter, with EPS growing +53.8% year-over-year.